⌘K

Login Start Free

Home/Filings/4/0001638599-17-000948

4//SEC Filing

Siewers David 4

Accession 0001638599-17-000948

CIK 0001453687other

View on SEC.gov Company Profile

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 5:30 PM ET

Size

13.6 KB

Accession

0001638599-17-000948

Insider Transaction Report

Form 4

Period: 2017-09-20

SELECTA BIOSCIENCES INCSELB

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2017-09-20$0.63/sh+2,194$1,382→ 2,194 total
Sale
Common Stock
2017-09-20$20.00/sh−2,194$43,880→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2017-09-20−14,230→ 5,000 total
Exercise: $0.63Exp: 2021-02-16→ Common Stock (14,230 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2017-09-20−2,194→ 0 total
Exercise: $0.63Exp: 2020-09-06→ Common Stock (2,194 underlying)
Exercise/Conversion
Common Stock
2017-09-20$0.63/sh+14,230$8,965→ 14,230 total
Sale
Common Stock
2017-09-20$20.00/sh−14,230$284,600→ 0 total

Footnotes (2)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
[F2]All shares underlying this option are fully vested.

Documents

1 file

4
doc4_4980.xmlPrimary
PRIMARY DOCUMENT

Issuer

SELECTA BIOSCIENCES INC

CIK 0001453687

Entity typeother

Related Parties

1

filerCIK 0001676906

Filing Metadata

Form type: 4
Filed: Sep 21, 8:00 PM ET
Accepted: Sep 22, 5:30 PM ET
Size: 13.6 KB

View on SEC.gov